WELLVONE susp 750 mg/5ml 210 ml
7680535630151
CH-53563
P01AX06
08.04.3.
Reimbursement limitations:
WELLVONE
Traitement d'une pneumopathie à pneumocystis carinii (PPC) aiguë, légère à modérée (gradient d'oxygène alvéolo-arteriel [(A-a)DO2] …
1 / 3
google
Details
- Product number
- 5356301
- CPT
- -
- Packaging group
- 210
- Unit
- ml
- Composition
- atovaquonum 750 mg, alcohol benzylicus 50 mg, xanthani gummi, poloxamerum 188, saccharinum natricum corresp. natrium 0.95 mg, aromatica (Vielfrucht) cum aurantii dulcis aetheroleum, aurantii dulcis aetheroleum concentratum, propylenglycolum, alcohol benzylicus 0.66 mg, vanillinum, acetaldehydum, ethylis butyras et amylis acetas, aqua purificata q.s. ad suspensionem pro 5 ml.
Articles (1)
Wellvone, Suspension
suspension
210
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
750.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
50.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
0.95 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
0.66 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 486.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 53563
- Drug name
- Wellvone, Suspension
- Galenic form
- SUOR
- ATC Code
- P01AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/05/1996
- Authorization expiration date
- 31/12/9999
- IT number
- 08.04.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- WELLVONE susp 750 mg/5ml 210 ml
- Description (DE)
- WELLVONE Susp 750 mg/5ml 210 ml
- Market launch
- 29/05/1996
- Narcotic (BTM)
- No